Genetic Engineering Market Size Worth USD 5811 Million by 2030 at 24.20% CAGR - Report by Market Research Future (MRFR)
October 13, 2022 11:30 ET
|
Market Research Future
New York, USA, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Genetic Engineering Market Overview: According to a Comprehensive Research Report by Market Research Future (MRFR), “Genetic Engineering Market...
Ocugen Announces Completion of Dosing in OCU400 Phase 1/2 Cohort 2
October 12, 2022 17:37 ET
|
Ocugen
• No safety concerns noted in ongoing clinical trial• Study timeline remains on track MALVERN, Pa., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a...
Genomics in Cancer Care Market is estimated to be US$ 72.61 billion by 2032 with a CAGR of 16.3% during the forecast period 2032 - By PMI
October 11, 2022 08:45 ET
|
PMI
Covina, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Genomics is the study of all of person’s gene. Genomics play role in health and disease. Genomics are widely used in cancer care treatment for diagnosing...
Global Cell and Gene Therapy (CGT) Market Analysis Report 2022: Shift to Prevalent Diseases and Allogeneic Cell Therapies Creates New Growth Opportunities in the CGT Value Chain
October 07, 2022 06:38 ET
|
Research and Markets
Dublin, Oct. 07, 2022 (GLOBE NEWSWIRE) -- The "Global Cell and Gene Therapy (CGT) Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. This study examines the global...
Ocugen, Inc. to Present at Upcoming Vaccines, Cell & Gene Therapy Conferences
October 06, 2022 08:00 ET
|
Ocugen
MALVERN, Pa., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene...
Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market Report 2022: Increasing Number of Cell & Gene Therapies Priming Sector for Substantial Growth
October 06, 2022 05:23 ET
|
Research and Markets
Dublin, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing, Non-Viral Vector Manufacturing and Gene Therapy Manufacturing Market by Scale of Operation, Type of Vector, Application...
DNA and Gene Cloning Services Global Market Report 2022: Growing Demand for Gene Therapies Fueling Sector Expansion
October 06, 2022 05:18 ET
|
Research and Markets
Dublin, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The "DNA and Gene Cloning Services Market: Distribution by Type of Service Offered, Type of Gene, Company Size, End-User Industry and Key Geographies:...
Tenaya Therapeutics to Present Preclinical Data on Its Novel Engineered AAV Capsids for Cardiac Gene Delivery at the ESGCT 29th Annual Congress
October 04, 2022 08:30 ET
|
Tenaya Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...
Freeline Initiates Dosing of Second Cohort in MARVEL-1 Trial of FLT190 Gene Therapy Candidate for People with Fabry Disease
October 04, 2022 07:00 ET
|
Freeline Therapeutics Holdings plc
LONDON, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that the first patient has been dosed in the second dose cohort of the Phase 1/2 MARVEL-1...
uniQure to Participate in Upcoming Industry Conferences in October
October 03, 2022 07:05 ET
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, Oct. 03, 2022 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...